← back to search

Erica N. Borducchi

Harvard University · US
Area of research
Virology · Genetics
Research interest
Research interests include HIV Research and Treatment, Virus-based gene therapy research, Virology and Viral Diseases, and Immune Cell Function and Interaction.
h-index
38
citations
8,096
works
100
NIH funding
primary concept
Medicine
email

Recent publications

Mining the CD4 antigen repertoire for next-generation tuberculosis vaccines
Cell 2025cited by 12position: middledoi
Origin and Correlates of Viral Rebound in SIV-Infected Rhesus Macaques Following ART Discontinuation
bioRxiv (Cold Spring Harbor Laboratory) 2025cited by 2position: middledoi
Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study
EBioMedicine 2024cited by 16position: middledoi
Immunogenicity of 2 therapeutic mosaic HIV-1 vaccine strategies in individuals with HIV-1 on antiretroviral therapy
npj Vaccines 2024cited by 6position: middledoi
Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women
JAMA 2021cited by 419position: middledoi
Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans
Nature 2021cited by 349position: middledoi
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19
JAMA 2021cited by 334position: middledoi
Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)
The Lancet 2018cited by 341position: middledoi
Ad26/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys
Nature 2016cited by 271position: firstdoi
Vaccine-elicited CD4 T cells induce immunopathology after chronic LCMV infection
Science 2015cited by 80position: middledoi
Rapid seeding of the viral reservoir prior to SIV viraemia in rhesus monkeys
Nature 2014cited by 628position: middledoi
Therapeutic efficacy of potent neutralizing HIV-1-specific monoclonal antibodies in SHIV-infected rhesus monkeys
Nature 2013cited by 637position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Dan H. Barouch · Harvard University3 papers (2015–2025) · 2 papers (2025–2025)Daniel Sellers · Beth Israel Deaconess Medical Center1 papers (2025–2025)Charles Goodman · UCLA Health1 papers (2025–2025)Jeffrey D. Lifson · Center for Cancer Research1 papers (2025–2025)Emek Köse · University of Tennessee at Knoxville1 papers (2025–2025)W. Nicholas Haining · Broad Institute1 papers (2015–2015) · 1 papers (2025–2025)Behnaz Eshaghi · Massachusetts Institute of Technology1 papers (2025–2025)Thomas J. Scriba · South African Tuberculosis Vaccine Initiative1 papers (2025–2025)Daniel L. Barber · National Institute of Allergy and Infectious Diseases1 papers (2015–2015)Brandon F. Keele · Center for Cancer Research1 papers (2025–2025)E. John Wherry · Translational Therapeutics (United States)1 papers (2015–2015)Hao Shen · Chinese PLA General Hospital1 papers (2015–2015)Kathleen B. Yates · Broad Institute1 papers (2015–2015)Ana Jaklenec · Massachusetts Institute of Technology1 papers (2025–2025)Daniel D. Pinschewer · University of Basel1 papers (2015–2015)Shoko Wakabayashi · University of Massachusetts Chan Medical School1 papers (2025–2025)Julia Barrett · Yale University1 papers (2025–2025) · 1 papers (2015–2015)